| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/28/2008 | CN100390201C Fusion protein with reinforced erythrocytin activity in vivo |
| 05/28/2008 | CN100390194C Low hemolytic antibacterial peptide and its application |
| 05/27/2008 | US7378490 a cyclic dodecapeptide containing Arg, Asp, Ala, Glu, Ser, Gly, Ala; cyclic peptides serve as antigens for producing a neutralizing antibody capable of neutralizing HIV-1 virus infection via the second receptors called CXCR4 and CCR5 |
| 05/27/2008 | US7378489 Polypeptide immunogen comprising N-acetyl-Cys-Gly-angiotensin I; immunotherapy of conditions associated with the renin activated angiotensin system such as hypertension |
| 05/27/2008 | US7378488 for promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 05/27/2008 | US7378485 A compound containing a polyamide backbone bearing a plurality of ligands that are individually bound to aza nitrogen atoms loacted within the backbone and atleast one ligand is a nucleobase, a DNA intercalator or nucleobase binder |
| 05/27/2008 | US7378422 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 05/27/2008 | US7378234 Method for isolating hepatitis C virus peptides |
| 05/27/2008 | CA2413629C Solid method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 05/27/2008 | CA2117181C Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 05/22/2008 | WO2008058922A1 Marker specific to an oxidation degradation of tissues containing type iii collagen, means and methods, and kits for the tracking diagnosis or prognosis of pathologies targeted by said marker |
| 05/22/2008 | WO2007144771A3 Peptides that mimic non-human cross-reactive protective epitopes of the group b meningococcal capsular polysaccharide |
| 05/22/2008 | WO2006059913A9 Modulation of ovulation |
| 05/22/2008 | US20080119569 Polymer-based sustained release device |
| 05/22/2008 | US20080119412 Polypeptides for Modulating Binding of Trp Channel Proteins and Trp- Associated Proteins |
| 05/22/2008 | US20080119405 Fowlicidins and Methods of Their Use |
| 05/22/2008 | US20080119397 Kahalalide Compositions |
| 05/22/2008 | US20080119395 Novel Depsipeptides and Process for Preparing Same |
| 05/22/2008 | US20080118941 For imaging live cells and subcellular trafficking processes; electroporation |
| 05/22/2008 | US20080118525 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 05/22/2008 | US20080118523 Chimeric polypeptide comprising tissue inhibitor of matrix metalloproteinases-3 (TIMP-3) for use in treatment and prevention of arthritic and degenerative joint disorders |
| 05/22/2008 | US20080118464 For diagnosis, genetic engineering; post-translation modification |
| 05/21/2008 | EP1923463A1 Cancer-rejection antigen peptide derived from glypican-3 (gpc3) for use in hal-a2-positive patient and pharmaceutical comprising the antigen |
| 05/21/2008 | EP1923398A1 Process for producing a polypeptide |
| 05/21/2008 | EP1923397A1 Fluorinated amino acids and peptides |
| 05/21/2008 | EP1922381A1 Printable materials |
| 05/21/2008 | EP1922330A1 Pseudomonas exotoxin a cd4+ t-cell epitopes |
| 05/21/2008 | EP1922328A1 Peptides targeted to protein kinase c isoforms and uses thereof |
| 05/21/2008 | EP1922086A1 Targeted protein kinase c inhibitors and uses thereof |
| 05/21/2008 | EP1495318A4 Method for detecting ligands and targets in a mixture |
| 05/21/2008 | EP1078002B1 Peptide antiangiogenic drugs |
| 05/21/2008 | CN101184769A Diagnostic and therapeutic agents |
| 05/21/2008 | CN101184502A Polypeptides |
| 05/21/2008 | CN101182349A Recombinant octreotide and uses thereof |
| 05/21/2008 | CN100389126C Endothelial cell proliferation inhibitor and method of use |
| 05/20/2008 | US7375181 Process for purifying glycopeptide phosphonate derivatives |
| 05/20/2008 | US7375079 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression |
| 05/20/2008 | US7375073 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
| 05/20/2008 | US7374896 GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity |
| 05/20/2008 | US7374894 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein |
| 05/20/2008 | US7374767 cyclic peptides blocking of the Casein Kinase II (CKII) phosphorylation domain; HPV-16 cervical carcinoma cells; peptides increase the sensitivity of the cells to the cytostatic effect of IFN |
| 05/20/2008 | CA2229202C Methods for identifying antagonist or agonist to human opioid receptor-like 1 "orl1" |
| 05/20/2008 | CA2219819C Novel compounds, the preparation and use thereof |
| 05/20/2008 | CA2219818C Novel compounds, the preparation and use thereof |
| 05/15/2008 | WO2008058166A2 Decorative floor and deck finish and method for creating and applying such a finish |
| 05/15/2008 | WO2008057608A2 Synthetic peptide amides |
| 05/15/2008 | WO2008056623A1 Composition for introduction of nucleic acid |
| 05/15/2008 | WO2008056217A1 Process for the preparation of cyclic peptides |
| 05/15/2008 | WO2008055488A1 Michael systems as transglutaminase inhibitors |
| 05/15/2008 | WO2008014603A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/15/2008 | WO2006126102A8 Compositions and methods for fusion protein separation |
| 05/15/2008 | US20080114152 Peptide compounds |
| 05/15/2008 | US20080113918 Oral, intravenous, skin or nasal dosage form of agonist polypeptide containing amino acid sequence FCIGRL with less than 100 amino acid residues in length; antiinflmmatory agents |
| 05/15/2008 | US20080113917 A fusion protein expressed in a protease resistant scaffold and protease inhibitor is selected from the group consisting of Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor; capable of modulating human hair growth |
| 05/15/2008 | US20080113909 Compositions and Methods for Treating Stat-6 Associated Diseases or Conditions |
| 05/15/2008 | US20080113899 Iron Supplement and Utilization of the Same |
| 05/15/2008 | US20080113897 Dividing continuous process into two sequences; industrial waste used is optimized; range of products obtained is broadened; fat, calcium salt, liquid peptide solution; mineral acid, heavy metals hydrolysis accelerator; autoclave; neutralize; filter press |
| 05/15/2008 | US20080113396 Kits and peptides for transferases |
| 05/15/2008 | US20080112926 Preparing chimeric polypeptide comprising glycosaminoglycan-binding proteins (GAG) for use in prevention and treatment of skin, nervous system and inflammatory disorders |
| 05/15/2008 | CA2667155A1 Synthetic peptide amides |
| 05/15/2008 | CA2662876A1 Michael systems as transglutaminase inhibitors |
| 05/14/2008 | EP1921088A2 Peptides and related molecules that bind to tall-1 |
| 05/14/2008 | EP1921087A1 Process for the preparation of cyclic peptides |
| 05/14/2008 | EP1919933A2 Gdnf derived peptides |
| 05/14/2008 | EP1919513A1 Target vector with activable imaging function |
| 05/14/2008 | EP1919491A2 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 05/14/2008 | EP1664332A4 Kinase and phosphatase assays |
| 05/14/2008 | EP1622930B1 Template-fixed peptidomimetics as medicaments against hiv and cancer |
| 05/14/2008 | EP1309355B1 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 05/14/2008 | EP1067950B1 Neo-tryptophan |
| 05/14/2008 | EP0840749B1 The h-y antigen |
| 05/14/2008 | CN101180307A Ionic liquid supported synthesis |
| 05/14/2008 | CN101177450A Short-peptide triggering male penis erection and improving female libido |
| 05/14/2008 | CN100387713C Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
| 05/14/2008 | CN100387622C Strategically modified hepatitis b core proteins and their derivatives |
| 05/14/2008 | CN100387619C Regulatory/unfolding peptides of ezrin |
| 05/14/2008 | CN100387616C Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/13/2008 | US7371921 Nonhuman animal model non-responsive to mycoplasma-origin lipoprotein/lipopeptide |
| 05/13/2008 | US7371813 Method for use of IGF-binding protein for selective sensitization of target cells in vivo |
| 05/13/2008 | US7371811 Polypeptide of given sequence; diagnosis and treatment of bipolar disorders |
| 05/13/2008 | US7371810 Tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 05/13/2008 | US7371809 Pharmacologically active antiviral peptides |
| 05/13/2008 | US7371728 Prostate peptide substrate: Gly-Hyp-Ala-Ser-Chg-Gln-Ser-Leu-Met-Lys(FITC)-Cys-NH2 where Hyp is hydroxyproline, Chg is cyclohexylglycine and FITC is Fluorescein isothiocyanate; near-infrared fluorescence probe |
| 05/13/2008 | US7371724 use in screening for compounds which interacts with Fc epsilon RI alpha; able to inhibit the IgE-induced mediator release without affecting the binding of IgE to the same receptor |
| 05/13/2008 | US7371720 Cationic peptides of the phylloseptin family isolated from the skin secretion of Phyllomedusa hypochondrialis |
| 05/13/2008 | US7371559 Polynucleotide of given sequence; treatment of chronic pain, migraine, asthma, urge incontinence, psoriasis, and cancer |
| 05/13/2008 | US7371386 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/13/2008 | US7371364 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
| 05/13/2008 | CA2301717C Peptide with radio protective effect |
| 05/08/2008 | WO2008054746A1 Peptides having affinity for body surfaces and modified by attachment of charged block at least one extremity |
| 05/08/2008 | WO2008054030A1 IgG-BINDING PEPTIDE |
| 05/08/2008 | WO2008053573A1 Remedy for malignant neoplasm |
| 05/08/2008 | WO2008052428A1 Preparation method and conjugate with drug molecule thereof |
| 05/08/2008 | WO2008052295A1 Process for the preparation of compounds of at1 receptor antagonists with angiotensin-(1-7), analogues thereof and/or mixtures of these systems, pharmaceutical compositions thereof and use of their derivative products |
| 05/08/2008 | WO2008026040A3 68ga-labeled peptide-based radiopharmaceuticals |
| 05/08/2008 | WO2007124284B1 Bombesin receptor anatogonists with anti-cancer activity |
| 05/08/2008 | WO2007083112A3 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae |
| 05/08/2008 | WO2006056487A3 Peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 05/08/2008 | US20080108790 S-Alkyl-Sulphenyl Protection Groups in Solid-Phase Synthesis |
| 05/08/2008 | US20080108789 Biological scaffold composed of an avian pancreatic polypeptide comprised of leucine zipper domain for use in designing modulators for prevention and treatment of cell proliferative disorders |